Baird Financial Group, Inc. - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 216 filers reported holding EDITAS MEDICINE INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
Baird Financial Group, Inc. ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q3 2023$202,527
-2.7%
25,965
+2.7%
0.00%0.0%
Q2 2023$208,046
+14.5%
25,279
+0.9%
0.00%
Q1 2023$181,692
+119434.2%
25,061
+46.1%
0.00%
Q4 2022$152
-99.9%
17,157
+57.8%
0.00%
Q3 2022$133,000
+6.4%
10,872
+3.6%
0.00%
Q2 2022$125,000
-39.0%
10,498
-2.5%
0.00%
-100.0%
Q1 2022$205,000
-22.6%
10,763
+8.0%
0.00%0.0%
Q4 2021$265,0009,9630.00%
Other shareholders
EDITAS MEDICINE INC shareholders Q3 2023
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 54,615$4,897,0002.55%
Capital Impact Advisors, LLC 130,000$9,114,0002.24%
ARK Investment Management 10,125,564$709,903,0001.89%
Nikko Asset Management Americas, Inc. 4,388,143$307,653,0001.75%
Spectrum Planning & Advisory Services Inc. 17,522$1,228,0001.32%
DDD Partners, LLC 79,527$5,576,0001.10%
Brevan Howard Capital Management LP 76,420$5,358,0001.08%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 538,721$37,770,0000.75%
DC Investments Management, LLC 3,627$254,0000.63%
Haafor (Singapore) Pte. Ltd. 4,761$334,0000.62%
View complete list of EDITAS MEDICINE INC shareholders